Finance

Lists
Why is FAE down २.२४%?
Dive Deeper
FAE:BME
FAES Farma SA
€ ४.८०
-२.२४%
(-०.११) 1D
अक्टोबर १३, १७:३६:०० GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for FAE...
Open
€ ४.९२
High
€ ४.९४
Low
€ ४.७६
Mkt. cap
१.५९ अरब
Avg. vol.
१.९५ लाख
Volume
१.६४ लाख
Dividend
२.६७%
Quarterly dividend
€ ०.०३
Ex-dividend date
२०२६ जुलाई २
P/E ratio
१७.८५
52-wk high
€ ५.४४
52-wk low
€ ४.३२
EPS
€ ०.२७
Shares outstanding
३१.६२ करोड
No. of employees
३ हजार
Open
€ ४.९२
High
€ ४.९४
Low
€ ४.७६
Mkt. cap
१.५९ अरब
Avg. vol.
१.९५ लाख
Volume
१.६४ लाख
Dividend
२.६७%
Quarterly dividend
€ ०.०३
Ex-dividend date
२०२६ जुलाई २
P/E ratio
१७.८५
52-wk high
€ ५.४४
52-wk low
€ ४.३२
EPS
€ ०.२७
Shares outstanding
३१.६२ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
१४ मिनेट पहिले
Nasdaq cuts target for VolitionRx stock to USD 13.89
JournalArta
JournalArta
·
५७ मिनेट पहिले
Stock Market Dow S&P Slip as Chip Stocks Weigh on Wall Street
Investor's Business Daily
Investor's Business Daily
·
१ घण्टा पहिले
Tech Futures Rise: Meta, AMD Lead 5 Buys; ASML, CPI Inflation Due
Profile
Faes Farma, originally Fábrica Española de Productos Químicos y Farmacéuticos, is a Spanish pharmaceutical company based in the Lamiaco district of Lejona in Biscay. Founded on 29 July 1933 by the Serra family with an initial capital of two million pesetas, it pioneered the development of various therapeutic compounds and has been listed on the Madrid Stock Exchange since the 1940s. Faes Farma’s headquarters, production facilities, and R&D center are located in Lejona, with additional offices in Madrid and Barcelona. The group also operates subsidiaries in Portugal, Italy, Mexico, Guatemala, Colombia, Chile, Peru, Bolivia, Ecuador and Nigeria, and maintains an animal nutrition and health division under the name FARM Faes. Wikipedia
About FAES Farma SA
CEO-
Employees२.६१ हजार
Founded१९३३ जुलाई २९
Headquarters-
Sector-
Last report
२०२६ जुलाई ३०
Fiscal period
Q2 2026
€ ०.०९ / -
०.००%miss
Revenue / Est. (EUR)
४०.१८ करोड / १८.९६ करोड
+१११.८९%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१४.६६ करोड
१७.३० करोड
२०.०१ करोड
१९.१४ करोड
Cost of goods sold
५.२४ करोड
७.३४ करोड
६.१६ करोड
६.०२ करोड
Cost of revenue
५.२४ करोड
७.३४ करोड
६.१६ करोड
६.०२ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.७४ करोड
८.०८ करोड
४.५७ करोड
४.४१ करोड
Operating expense
६.८१ करोड
९.८४ करोड
१०.०१ करोड
९.८५ करोड
Total operating expenses
१२.०५ करोड
१७.१९ करोड
१६.१७ करोड
१५.८८ करोड
Operating income
२.६१ करोड
११.०९ लाख
३.८४ करोड
३.२६ करोड
Other non operating income
४.०१ लाख
१०.१८ लाख
-
-
EBT including unusual items
२.५२ करोड
-१३.९० लाख
३.६४ करोड
३.०५ करोड
EBT excluding unusual items
२.५२ करोड
-१६.५३ लाख
३.६४ करोड
३.०५ करोड
Income tax expense
३७.५३ लाख
-७४.२९ लाख
५४.९० लाख
४३.२४ लाख
Effective tax rate
१४.९१%
५३४.४६%
१५.१०%
१४.१९%
Other operating expenses
३.३७ करोड
७२.१२ लाख
४.४६ करोड
४.४४ करोड
Net income
२.१२ करोड
६०.६९ लाख
३.०८ करोड
२.६१ करोड
Net profit margin
१४.४८%
३.५१%
१५.३९%
१३.६४%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
१४.०७ लाख
Interest expense
-१९.८८ लाख
-३५.१४ लाख
-१९.९१ लाख
-३५.८४ लाख
Net interest expenses
-१९.८८ लाख
-३५.१४ लाख
-१९.९१ लाख
-२१.७७ लाख
Depreciation and amortization charges
७०.५० लाख
१.०४ करोड
९८.३३ लाख
१.०० करोड
EBITDA
३.०१ करोड
६९.४२ लाख
४.४२ करोड
४.०५ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू